饮食和腹的管理
Sahana Shankar1, Emmany Durairaj2
1Division of Pediatric Gastroenterology, Department of Pediatrics, Mazumdar Shaw Medical Center, Narayana Health, Bangalore, India. drsahanashankar@gmail.com.
Indian journal of pediatrics
|July 22, 2023
概括
饮食改变可以治疗和引起腹. 本综述侧重于如何通过饮食来管理儿童腹,特别是先天性腹,同时警告排除饮食的潜在风险.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 营养科学 营养科学
- 人类健康和疾病
背景情况:
- 饮食显著影响人类健康和疾病,特别是腹疾病.
- 随着下一代测序的进步,先天性腹和肠道病变越来越被理解.
- 饮食修改是各种腹疾病的关键治疗方法.
研究的目的:
- 审查儿童腹的病因特异性饮食管理.
- 强调饮食在先天性腹和肠道疾病中的作用.
- 强调与慢性腹饮食干预相关的好处和风险.
主要方法:
- 关于饮食和儿科腹的当前文献的综述.
- 对先天性腹和肠病的诊断和治疗方法的分析.
- 讨论饮食修改对慢性腹管理的影响.
主要成果:
- 早期的饮食治疗对于先天性透性腹至关重要.
- 识别和排除有害食物可以大大改善慢性腹的症状.
- 排除饮食需要谨慎,因为存在微量营养素缺乏和不适应性饮食行为的风险.
结论:
- 饮食管理是治疗儿科腹,特别是先天性腹的基石.
- 个性化,病因特定的饮食干预措施对于最佳结果至关重要.
- 需要一种平衡的方法来最大限度地提高治疗效益,同时最大限度地降低饮食限制的风险.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
356
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
356
Irritable Bowel Syndrome III: Medical and Nursing Management
244
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
244
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
Drugs for Treatment of Diarrhea-Predominant IBS
216
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
216
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
251
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
251
Inflammatory Bowel Disease IV: Pharmacological Management
154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
154


